Biotech Firm Loses Rights To Bone Growth Patent
A Kansas medical firm developing therapies to fight osteoporosis has failed to convince European appellate officials that it deserves a patent covering a method of altering bone growth by using specific...To view the full article, register now.
Already a subscriber? Click here to view full article